Last reviewed · How we verify
Placebo matching Metformin XR — Competitive Intelligence Brief
phase 3
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo matching Metformin XR (Placebo matching Metformin XR) — AstraZeneca. This is a placebo formulation designed to match the appearance and administration profile of Metformin XR for use as a control in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo matching Metformin XR TARGET | Placebo matching Metformin XR | AstraZeneca | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo matching Metformin XR CI watch — RSS
- Placebo matching Metformin XR CI watch — Atom
- Placebo matching Metformin XR CI watch — JSON
- Placebo matching Metformin XR alone — RSS
Cite this brief
Drug Landscape (2026). Placebo matching Metformin XR — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matching-metformin-xr. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab